Development of outcome measures for giant cell arteritis for use in clinical trials and standard practice.
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 11, p. 3049, doi. 10.1007/s10067-023-06704-7
- By:
- Publication type:
- Article
Works by Elgaafary, Maha
Results: 9
1
2
Towards a holistic approach of Giant Cell Arteritis management: Predictors of relapse after initial treatment - results of a prospective follow up study.
- Published in:
- Egyptian Rheumatology & Rehabilitation, 2025, v. 52, n. 1, p. 1, doi. 10.1186/s43166-025-00322-8
- By:
- Publication type:
- Article
3
Development and evaluation of disease-specific patient-reported outcome measures questionnaire for polymyalgia rheumatica: validity, reliability, and responsiveness.
- Published in:
- Egyptian Rheumatology & Rehabilitation, 2025, v. 52, n. 1, p. 1, doi. 10.1186/s43166-025-00318-4
- By:
- Publication type:
- Article
4
The development of the Egyptian 24-h movement guidelines for adults aged 18–50 years old: an integration of sleep, sedentary behavior, and physical activity by the Egyptian Academy of Bone and Muscle Health.
- Published in:
- Egyptian Rheumatology & Rehabilitation, 2024, v. 51, n. 1, p. 1, doi. 10.1186/s43166-024-00294-1
- By:
- Publication type:
- Article
5
The Egyptian 24-h movement guidelines for children and adolescents: an integration of physical activity, sedentary behaviour, sleep and eating habits—by the Egyptian Academy of Bone and Muscle health.
- Published in:
- Egyptian Rheumatology & Rehabilitation, 2024, v. 51, n. 1, p. 1, doi. 10.1186/s43166-024-00279-0
- By:
- Publication type:
- Article
6
Predicting the probability of osteoporotic fracture risk in men versus women: do we need specific reference interventional thresholds for men?
- Published in:
- Egyptian Rheumatology & Rehabilitation, 2024, v. 51, n. 1, p. 1, doi. 10.1186/s43166-024-00270-9
- By:
- Publication type:
- Article
7
Osteoporosis clinical practice guideline: romosozumab for treating severe osteoporosis – an update by the Egyptian Academy of Bone Health.
- Published in:
- Egyptian Rheumatology & Rehabilitation, 2022, v. 49, n. 1, p. 1, doi. 10.1186/s43166-022-00150-0
- By:
- Publication type:
- Article
8
Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-85227-0
- By:
- Publication type:
- Article
9
Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice